Citadel Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8M Sell
230,000
-172,100
-43% -$19.5M ﹤0.01% 2119
2025
Q4
$40.5M Buy
402,100
+139,700
+53% +$15.2M 0.01% 1611
2025
Q3
$32.4M Buy
262,400
+117,900
+82% +$14.6M ﹤0.01% 1798
2025
Q2
$17.4M Buy
144,500
+55,900
+63% +$7.46M ﹤0.01% 2317
2025
Q1
$13M Sell
88,600
-129,400
-59% -$19.8M ﹤0.01% 2529
2024
Q4
$35.4M Sell
218,000
-51,900
-19% -$8.49M 0.01% 1593
2024
Q3
$44M Sell
269,900
-230,200
-46% -$34.1M 0.01% 1339
2024
Q2
$68.2M Buy
500,100
+1,000
+0.2% +$139K 0.01% 906
2024
Q1
$76.4M Sell
499,100
-62,200
-11% -$9.28M 0.01% 895
2023
Q4
$80M Buy
561,300
+76,800
+16% +$10.2M 0.02% 828
2023
Q3
$63.5M Buy
484,500
+189,100
+64% +$28.7M 0.01% 904
2023
Q2
$47M Sell
295,400
-55,700
-16% -$8.98M 0.01% 1104
2023
Q1
$55.6M Sell
351,100
-392,500
-53% -$58.9M 0.01% 990
2022
Q4
$104M Buy
743,600
+35,500
+5% +$5.04M 0.02% 631
2022
Q3
$90.9M Sell
708,100
-289,100
-29% -$41.7M 0.02% 652
2022
Q2
$141M Buy
997,200
+542,600
+119% +$77.5M 0.04% 411
2022
Q1
$63.2M Buy
454,600
+78,700
+21% +$12.1M 0.01% 950
2021
Q4
$65.5M Sell
375,900
-114,600
-23% -$19.1M 0.01% 960
2021
Q3
$81.2M Buy
490,500
+15,900
+3% +$2.74M 0.02% 777
2021
Q2
$85.4M Buy
474,600
+261,800
+123% +$47.8M 0.02% 763
2021
Q1
$41M Sell
212,800
-123,100
-37% -$23.7M 0.01% 1218
2020
Q4
$67.8M Sell
335,900
-175,200
-34% -$36.3M 0.02% 761
2020
Q3
$107M Buy
511,100
+158,300
+45% +$35.3M 0.03% 423
2020
Q2
$77.4M Buy
352,800
+116,200
+49% +$23.2M 0.03% 533
2020
Q1
$41M Buy
236,600
+103,000
+77% +$17M 0.02% 749
2019
Q4
$20.5M Sell
133,600
-5,100
-4% -$762K 0.01% 1453
2019
Q3
$21.1M Buy
138,700
+28,900
+26% +$4.57M 0.01% 1426
2019
Q2
$16.8M Buy
109,800
+31,400
+40% +$4.8M 0.01% 1598
2019
Q1
$12.6M Buy
78,400
+4,200
+6% +$652K 0.01% 1804
2018
Q4
$11.4M Sell
74,200
-92,600
-56% -$14.4M 0.01% 1746
2018
Q3
$25.1M Sell
166,800
-22,700
-12% -$3.22M 0.01% 1217
2018
Q2
$25.6M Buy
189,500
+133,100
+236% +$16.4M 0.01% 1117
2018
Q1
$7.51M Buy
56,400
+13,500
+31% +$1.81M ﹤0.01% 2010
2017
Q4
$6.38M Sell
42,900
-7,000
-14% -$952K ﹤0.01% 2184
2017
Q3
$6.58M Buy
49,900
+6,900
+16% +$927K 0.01% 2004
2017
Q2
$5.73M Buy
43,000
+8,400
+24% +$1.13M ﹤0.01% 1984
2017
Q1
$4.67M Sell
34,600
-11,700
-25% -$1.52M ﹤0.01% 2121
2016
Q4
$5.56M Sell
46,300
-12,400
-21% -$1.46M 0.01% 1894
2016
Q3
$7.35M Buy
58,700
+27,500
+88% +$3.6M 0.01% 1633
2016
Q2
$4.32M Sell
31,200
-20,200
-39% -$2.62M ﹤0.01% 1944
2016
Q1
$6.48M Buy
51,400
+18,900
+58% +$2.4M 0.01% 1540
2015
Q4
$4.12M Sell
32,500
-4,900
-13% -$608K ﹤0.01% 1992
2015
Q3
$4.32M Buy
37,400
+12,500
+50% +$1.4M ﹤0.01% 2092
2015
Q2
$2.59M Buy
24,900
+1,800
+8% +$194K ﹤0.01% 2763
2015
Q1
$2.55M Sell
23,100
-23,600
-51% -$2.56M ﹤0.01% 2764
2014
Q4
$4.87M Sell
46,700
-6,900
-13% -$690K ﹤0.01% 2001
2014
Q3
$5.15M Sell
53,600
-5,100
-9% -$461K 0.01% 1958
2014
Q2
$5.37M Sell
58,700
-41,200
-41% -$3.69M 0.01% 1771
2014
Q1
$8.79M Sell
99,900
-40,100
-29% -$3.52M 0.01% 1354
2013
Q4
$13M Buy
140,000
+48,500
+53% +$4.37M 0.02% 1054
2013
Q3
$7.48M Buy
91,500
+36,500
+66% +$3.08M 0.01% 1285
2013
Q2
$4.57M Buy
+55,000
New +$4.73M 0.01% 1662

Other funds holding CLX

Citadel Advisors's CLX Position: Q1 2026 in Review

Citadel Advisors reduced its Clorox (CLX) stake by 0.2% in Q1 2026, selling an estimated $319K and leaving 1,426,468 shares worth $148M. The position accounts for 0.02% of the portfolio, ranked #598.

Citadel Advisors first reported a position in CLX in Q2 2013 and has held it in 48 quarters since. The position peaked at $386M in Q2 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Citadel Advisors held 1,426,468 shares of Clorox worth $148M as of Q1 2026.
  • Citadel Advisors sold 2,816 Clorox shares in Q1 2026, an estimated $319K.
  • Clorox made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #598 holding.
  • Citadel Advisors first reported a position in Clorox in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Clorox position peaked at $386M in Q2 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.